• 0
MENU
Cart Details

Metcross LN 10mg/50mg Tablet ER

  • Home
  • Metcross LN 10mg/50mg Tablet ER

Product Informations: Metcross LN 10mg/50mg Tablet ER

In Hypertension (high blood pressure) Metcross LN 10mg/50mg Tablet ER relaxes the blood vessels so that blood can flow more easily around your body. It also blocks the effects of some chemicals on your heart and blood vessels. This slows down your heart rate and helps the heart beat with less force. As a result, your blood pressure is lowered and this helps in reducing your risk of having a stroke, a heart attack, other heart problems, or kidney problems in the future. This medicine needs to be taken regularly to be effective, so keep taking it even if you feel well. Do not stop without talking to your doctor.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metcross LN 10mg/50mg Tablet ER is to be taken with food.
Metcross LN 10mg/50mg Tablet ER is a medicine used to treat hypertension (high blood pressure). It is a combination of two medicines that effectively controls blood pressure when a single medication is not effective. By lowering the blood pressure, it helps in preventing future heart attack and stroke. You can take Metcross LN 10mg/50mg Tablet ER at any time of day, with food, but it is best to take it at the same time each day. Keep taking it for as long as advised by your doctor. Even if you feel well, do not stop this medicine on your own because high blood pressure often has no symptoms. If you stop taking it, your condition may get worse. Keeping active with regular exercise, reducing your weight and eating a healthy diet will also help control your blood pressure. Follow your doctor’s advice while taking this medicine. It may cause side effects like headache, ankle swelling, slow heart rate, and nausea. It may also cause dizziness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. To reduce the swelling, raise your legs while sitting down. You may be asked for regular monitoring of blood pressure, kidney function, blood sugar level, and electrolytes level while on the treatment. Before taking it, let your doctor know if you have any liver or kidney problems. Pregnant or breastfeeding women should also consult their doctor for advice before taking this medicine. You also need to tell your doctor what other medicines you are taking especially those used to treat high blood pressure or heart conditions.
Alcohol : UNSAFE

It is unsafe to consume alcohol with Metcross LN 10mg/50mg Tablet ER.

Pregnancy : CONSULT YOUR DOCTOR

Metcross LN 10mg/50mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding : CONSULT YOUR DOCTOR

Information regarding the use of Metcross LN 10mg/50mg Tablet ER during breastfeeding is not available. Please consult your doctor.

Driving : UNSAFE

Metcross LN 10mg/50mg Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney : CONSULT YOUR DOCTOR

There is limited information available on the use of Metcross LN 10mg/50mg Tablet ER in patients with kidney disease. Please consult your doctor.

Liver : CAUTION

Metcross LN 10mg/50mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Metcross LN 10mg/50mg Tablet ER may be needed. Please consult your doctor.

If you miss a dose of Metcross LN 10mg/50mg Tablet ER, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More



Available options.

Same salt composition: Cilnidipine (10mg) + Metoprolol Succinate (50mg)

Test Buy medical disposable face mask
to protect your loved ones